Effects of advanced glycation end products on expressions of EMMPRIN and MMP-2 in mouse osteoblasts

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 7, 2010, Pages 453-464

  Dai, Rongfeng ^a,b   Wang, Li ^a   Jin, Hui ^a   Sun, Zilin ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b No 3 People's Hospital   (China)

Author keywords

Advanced glycation end products; Extracellular matrix metalloproteinase inducer; Matrix metalloproteinase 2; Osteoblast; Osteoporosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD147 ANTIGEN; GELATINASE A; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; INCUBATION TIME; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ZYMOGRAPHY;

EID: 77957683466     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Antonio D (1997). Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Mol. Cell Biochem., 170: 43-45.
2. Berditcheriski F, Chang S, Bodorova J, Martin E (1997). Generation of monoclonal antibodies to integrin-associated proteins: evidence that α3β1 complexes with EMMPRIN/basigin/OX47 /M6[J]. Biol. Chem., 272: 29174-29180.
3. Cortizo AM, Caporossi M, Lettieri G, Susana B (2000). Vanadate induced nitric oxide production: role in osteoblast growth and differentiation. Eur. J. Pharmaacaol., 400(2-3): 279-285.
4. Guo H, Li R, Zucker S, Bryan B (2000). EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 60: 888-891.
5. Holliday LS, Vakani A, Archer L, Dolce C (2003). Effecta of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement[J]. Dent. Res., 82(9): 687-691.
6. Kasinrerk W, Fiebiger E, Stefanova I, Baumruker T, Knapp W, Stockinger H (1992). Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin and chicken HT7 molecule[J]. Immunol., 149: 847-854.
7. Katayama Y, Akatsy T, Yamamoto M, Kugai N, Nagata N (1996). Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia[J]. Bone Miner Res., 11: 931-937.
8. Kong DJ, Li E, Tong XX, Li ZH, Li B (2003). Effects of late advanced glycation end products on the osteoporosis induced by ovariectomy and therapeutic effects of aminoguanidine. [Zhong Guo Lao Nian Za Zhi] (Chinese), 1(23): 40-42.
9. Kyoshi H, Noriko Y, Kiwamu Y, Yoshihiro M, Mitsutaka M, Shinsuke S, Haruki S, Kazuo I (2007). Soluble EMMPRIN stimulates the migration of HEP-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts. Arch. Histol. Cytol., 70: 267-277.
10. Liang L, Major T, Bocan T (2002). Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN)[J]. Gene., 282(122): 75-86
11. Lim M, Martinez T, Jablous D, Cameron R, Guo H, Toole B, Li J, Basbaum C (1998). Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p 38[J]. FEBS Lett., 441(1): 88-92.
12. Mclennan SV, Martell SK, Yue DK (2002). Effects of Mesangium Glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy[J]. Diabetes, 51(8): 2612-2618.
13. Miyata T, Kawai R, Taketomi S, Sprague SM (1996). Possible involvement of advanced glycation end-products in bone resorption. Nephrol Dial Transplant, 11(Suppl5): 54-57.
14. Munch G, Thome J, Foley P, Schinzel R, Riederer P (1997). Advanced glycation end products in ageing and Alzheimer,s disease[J]. Brain Res Brain Res. Rev., 23(2): 134-143.
15. Sato T, Foged NT, Delaisse JM (1998). The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors[J]. Bone Min.er Res., 13(1): 59-66.
16. Sun J, Hemler ME (2001). Regulation of MMP1 and MMP2 production through CD147/ interactions [J]. Cancer Res., 61: 2276-2281.
17. Taylor PM, Woodfield RJ, Hodgkin MN, Pettitt TR, Martin A, Kerr DJ, Wakelam MJ (2002). Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway [J]. Oncogene. 21: 5765-5772.
18. Vlassara H, Brownlee M, Manogub K, Manogub KR, Dinarello CA, Pasagian A (1988). Cachectin TNF and IL-1 induced by glucosemodified protein: role in normal tissues remodeling. Science, 240: 1546-1548.
19. Yuan ZQ, Feldman RI, Sun M, Olashaw NE, Coppola D, Sussman GE, Shelley SA, Nicosia SV, Cheng JQ (2002). Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells, J. Biol. Chem., 277(33): 29973-29982.